Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03569995Phase 2Unknown
[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma
Primary CNS Lymphoma
PrincipalinvestigatorStart date: 2018-11-30
NCT03439501Phase 2Unknown
Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]
Lymphoma, Extranodal NK-T-Cell
PrincipalinvestigatorStart date: 2018-01-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Samsung Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Seok Jin Kim, MD, PhD

Samsung Medical Center

Related
5 trials

Shared therapeutic areas:

Primary CNS Lymphoma

Worked with same sponsors:

CelltrionSamsung Medical Center
Similarity Score15%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Primary CNS Lymphoma
Similarity Score15%

Gerald Illerhaus, Prof

Klinikum der Landeshauptstadt Stuttgart gKAö

Related
1 trials

Shared therapeutic areas:

Primary CNS Lymphoma
Similarity Score15%

yue lu, MD.

Department of Hematological Oncology, Sun Yat-sen University Cancer Center

Related
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score15%

Chandramouli Nagarajan, MD FRCPath

Singapore General Hospital

Related
1 trials

Shared therapeutic areas:

Primary CNS Lymphoma
Similarity Score15%

Andrés J.M. Ferreri, MD

IRCCS Ospedale San Raffaele

Related
1 trials

Shared therapeutic areas:

Primary CNS Lymphoma
Similarity Score15%

Stefano Luminari, MD

Ematologia, AUSL IRCCS Reggio Emilia

Related
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score15%

Wyndham H Wilson, M.D.

National Cancer Institute (NCI)

Related
7 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score15%

ZhongJun Xia, MD/PHD

Department of Hematological Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China,

Related
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score15%

Weili Zhao, MD

Shanghai Rui Jin Hospital,Shanghai Jiao Tong University - School of Medicine

Related
1 trials

Shared therapeutic areas:

Lymphoma, Extranodal NK-T-Cell
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03569995Phase 2PrincipalInvestigator

[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

Primary CNS Lymphoma
Unknown
NCT03439501Phase 2PrincipalInvestigator

Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]

Lymphoma, Extranodal NK-T-Cell
Unknown

All 2 trials loaded